AvePoint insider plans $850K stock sale

AvePoint, Inc. (AVPT) is the issuer for a planned resale of common stock under Rule 144 by Brian Michael Brown, through the Brian M Brown Rev Trust.

Rhea-AI Filing Summary

AvePoint, Inc. (AVPT) is the issuer for a planned resale of common stock under Rule 144 by Brian Michael Brown, through the Brian M Brown Rev Trust. The notice covers up to 60,000 shares of AvePoint common stock, originally received as a restricted stock grant on July 7, 2022 as compensation.

The 60,000 shares have an aggregate market value of $850,162.54, based on AvePoint’s common stock, with 211,565,426 shares outstanding as of August 27, 2026. In the past three months, the trust reported multiple sales of AvePoint shares on dates including July 14, July 15, July 28, July 29, and August 24, 2026.

Key Figures

Shares to be sold under Rule 144: 60,000 shares of common stock Aggregate market value of securities to be sold: $850,162.54 Shares outstanding: 211,565,426 shares +3 more

6 metrics

Shares to be sold under Rule 144 60,000 shares of common stock AvePoint common shares covered by the Form 144 notice

Aggregate market value of securities to be sold $850,162.54 Value of the 60,000 AvePoint common shares covered by the notice

Shares outstanding 211,565,426 shares AvePoint common shares outstanding as of August 27, 2026

Shares sold on July 14, 2026 8,369 shares; $108,828.96 AvePoint shares sold by Brian M Brown Rev Trust on July 14, 2026

Shares sold on July 15, 2026 31,631 shares; $417,028.16 AvePoint shares sold by Brian M Brown Rev Trust on July 15, 2026

Shares sold on August 24, 2026 10,000 shares; $132,961.17 AvePoint shares sold by Brian M Brown Rev Trust on August 24, 2026

Key Terms

Rule 144, restricted stock grant, aggregate market value, attorney-in-fact

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock grant financial

"Common | 07/07/2022 | Restricted Stock Grant | Issuer"

A restricted stock grant is an award of company shares given to an employee or executive that cannot be sold or transferred until certain conditions are met, such as staying with the company for a set time or hitting performance goals. For investors, it signals how the company ties pay to future performance and can affect the number of shares outstanding and management’s incentives—think of it as a wrapped gift you only keep once you meet the requirements.

aggregate market value financial

"Common | Rockefeller Financial ... | 60000 | 850162.54 | 211565426"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

attorney-in-fact regulatory

"as attorney-in-fact for Brian Michael Brown"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for AVPT disclose about planned share sales?

The Form 144 covers a proposed sale of up to 60,000 shares of AvePoint, Inc. common stock by or for the account of Brian Michael Brown, held in the Brian M Brown Rev Trust, under Rule 144.

What is the market value of the AvePoint (AVPT) shares covered by this Form 144?

The notice states an aggregate market value of $850,162.54 for the 60,000 AvePoint common shares proposed to be sold under Rule 144.

How many AvePoint (AVPT) shares are outstanding according to this filing?

The filing reports that AvePoint has 211,565,426 shares outstanding of common stock as of August 27, 2026; this is a baseline figure, not the amount being sold.

What is the source of the AvePoint (AVPT) shares being sold under this Form 144?

The 60,000 AvePoint common shares were acquired via a restricted stock grant on July 7, 2022, issued by the company as compensation.

What AvePoint (AVPT) share sales occurred in the last three months for this account?

The Brian M Brown Rev Trust reported sales of AvePoint shares on July 14, 15, 28, 29, 2026, and August 24, 2026, with individual transactions including 8,369 shares and 31,631 shares among others.

Who is executing the AvePoint (AVPT) Form 144 on behalf of the seller?

The notice is signed by Daniel Gardea as a duly authorized representative of National Financial Services LLC, acting as attorney-in-fact for Brian Michael Brown.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/27/2026 - 04:37 PM EDT Accepted by SEC EDGAR 08/27/2026 - 04:37 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001865783
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	AvePoint, Inc.
SEC File Number	001-39048
Address of Issuer	525 WASHINGTON BLVD SUITE 1400 JERSEY CITY NEW JERSEY 07310
Phone	(201) 793-1111
Name of Person for Whose Account the Securities are To Be Sold	Brown Brian Michael
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Rockefeller Financial 200 South 10th Street Suite 950 Richmond VA 23219	60000	850162.54	211565426	08/27/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/07/2022	Restricted Stock Grant	Issuer			60000	07/07/2022	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Brian M Brown Rev Trust 525 Washington Blvd, Suite 1400 Jersey City NJ 07310	Avepoint Inc	07/14/2026	8369	108828.96
Brian M Brown Rev Trust 525 Washington Blvd, Suite 1400 Jersey City NJ 07310	Avepoint Inc	07/15/2026	31631	417028.16
Brian M Brown Rev Trust 525 Washington Blvd, Suite 1400 Jersey City NJ 07310	Avepoint Inc	07/28/2026	4824	63094.17
Brian M Brown Rev Trust 525 Washington Blvd, Suite 1400 Jersey City NJ 07310	Avepoint Inc	07/29/2026	5176	67590.28
Brian M Brown Rev Trust 525 Washington Blvd, Suite 1400 Jersey City NJ 07310	Avepoint Inc	08/24/2026	10000	132961.17

144: Remarks and Signature

Remarks	Shares are being sold form BRIAN M BROWN REV TRUST U/A 8/8/13
Date of Notice	08/27/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/16/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Daniel Gardea as a duly authorized representative of National Financial Services LLC, as attorney-in-fact for Brian Michael Brown
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)